VEGF blockade inhibits angiogenesis and reepithelialization of endometrium

FASEB Journal

Volumn 22, Issue 10, 2008, Pages 3571-3580

  Fan, Xiujun ^a   Krieg, Sacha ^a   Kuo, Calvin J ^a   Wiegand, Stanley J ^b   Rabinovitch, Marlene ^a   Druzin, Maurice L ^a   Brenner, Robert M ^c   Giudice, Linda C ^d   Nayak, Nihar R ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b REGENERON PHARMACEUTICALS INC   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hypoxia; Luminal epithelium; Mouse; Rhesus macaque; VEGF Trap

Indexed keywords

NEUROPILIN 1; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH FACTOR TRAP; VASCULOTROPIN; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR 2; HYBRID PROTEIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR; VEGF TRAP FUSION PROTEIN, RECOMBINANT; VEGF-TRAP FUSION PROTEIN, RECOMBINANT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DECIDUA; DRUG POTENCY; ENDOMETRIUM; EPITHELIUM CELL; EPITHELIZATION; EXPERIMENTAL MODEL; FEMALE; HYPOXEMIA; MENSTRUATION; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RHESUS MONKEY; SIGNAL TRANSDUCTION; STROMA CELL; TISSUE GROWTH; TISSUE REGENERATION; ANGIOGENESIS; ANIMAL; BIOSYNTHESIS; CELL MOTION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; MACACA; METABOLISM; MOUSE STRAIN; PHYSIOLOGY; REGENERATION; VASCULARIZATION;

MACACA MULATTA; MURINAE; PRIMATES;

ANIMALS; CELL MOVEMENT; ENDOMETRIUM; EPITHELIAL CELLS; FEMALE; MACACA MULATTA; MENSTRUATION; MICE; MICE, INBRED STRAINS; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; REGENERATION; STROMAL CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 54049128139     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.08-111401     Document Type: Article

References (35)

1. Jabbour, H. N., Kelly, R. W., Fraser, H. M., and Critchley, H. O. (2006) Endocrine regulation of menstruation. Endocr. Rev. 27, 17-46
2. Hess, A. P., Nayak, N. R., and Giudice, L. C. (2005) Oviduct and endometrium: cyclic changes in the primate oviduct and endometrium. In Knobil and Neill's Physiology of Reproduction, Vol. 1-2 (Neill, J. D., ed) pp. 337-381, Elsevier Science & Technology Books, New York, NY, USA
3. Ludwig, H., and Spornitz, U. M. (1991) Microarchitecture of the human endometrium by scanning electron microscopy: menstrual desquamation and remodeling. Ann. N. Y. Acad. Sci. 622, 28-46
4. Dvorak, H. F. (2005) Angiogenesis: update 2005. J. Thromb. Haemost. 3, 1835-1842
5. Carmeliet, P., and Jain, R. K. (2000) Angiogenesis in cancer and other diseases. Nature 407, 249-257
6. Ferrara, N., and Kerbel, R. S. (2005) Angiogenesis as a therapeutic target. Nature 438, 967-974
7. Gluzman-Poltorak, Z., Cohen, T., Herzog, Y., and Neufeld, G. (2000) Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165. J. Biol. Chem. 275, 18040-18045
8. Soker, S., Miao, H. Q., Nomi, M., Takashima, S., and Klagsbrun, M. (2002) VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding. J. Cell. Biochem. 85, 357-368
9. Takashima, S., Kitakaze, M., Asakura, M., Asanuma, H., Sanada, S., Tashiro, F., Niwa, H., Miyazaki, J. J., Hirota, S., Kitamura, Y., Kitsukawa, T., Fujisawa, H., Klagsbrun, M., and Hori, M. (2002) Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 99, 3657-3662
10. Halder, J. B., Zhao, X., Soker, S., Paria, B. C., Klagsbrun, M., Das, S. K., and Dey, S. K. (2000) Differential expression of VEGF isoforms and VEGF(164)-specific receptor neuropilin-1 in the mouse uterus suggests a role for VEGF(164) in vascular permeability and angiogenesis during implantation. Genesis 26, 213-224
11. Germeyer, A., Hamilton, A. E., Laughlin, L. S., Lasley, B. L., Brenner, R. M., Giudice, L. C., and Nayak, N. R. (2005) Cellular expression and hormonal regulation of neuropilin-1 and -2 messenger ribonucleic acid in the human and rhesus macaque endometrium. J. Clin. Endocrinol. Metab. 90, 1783-1790
12. Nayak, N. R., and Brenner, R. M. (2002) Vascular proliferation and vascular endothelial growth factor expression in the rhesus macaque endometrium. J. Clin. Endocrinol. Metab. 87, 1845-1855
13. Charnock-Jones, D. S., Sharkey, A. M., Rajput-Williams, J., Burch, D., Schofield, J. P., Fountain, S. A., Boocock, C. A., and Smith, S. K. (1993) Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol. Reprod. 48, 1120-1128
14. Girling, J. E., and Rogers, P. A. (2005) Recent advances in endometrial angiogenesis research. Angiogenesis 8, 89-99
15. Ferenczy, A., Bertrand, G., and Gelfand, M. M. (1979) Proliferation kinetics of human endometrium during the normal menstrual cycle. Am. J. Obstet. Gynecol. 133, 859-867
16. Smith, S. K. (2001) Regulation of angiogenesis in the endometrium. Trends Endocrinol. Metab. 12, 147-151
17. Holash, J., Davis, S., Papadopoulos, N., Croll, S. D., Ho, L., Russell, M., Boland, P., Leidich, R., Hylton, D., Burova, E., Ioffe, E., Huang, T., Radziejewski, C., Bailey, K., Fandl, J. P., Daly, T., Wiegand, S. J., Yancopoulos, G. D., and Rudge, J. S. (2002) VEGF-Trap: a VEGF blocker with potent antitumor effects. Proc. Natl. Acad. Sci. U. S. A. 99, 11393-11398
18. Raleigh, J. A., Calkins-Adams, D. P., Rinker, L. H., Ballenger, C. A., Weissler, M. C., Fowler, W. C. Jr., Novotny, D. B., and Varia, M. A. (1998) Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker. Cancer Res. 58, 3765-3768
19. Cooke, P. S., Buchanan, D. L., Young, P., Setiawan, T., Brody, J., Korach, K. S., Taylor, J., Lubahn, D. B., and Cunha, G. R. (1997) Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium. Proc. Natl. Acad. Sci. U. S. A. 94, 6535-6540
20. Lathi, R. B., Hess, A. P., Tulac, S., Nayak, N. R., Conti, M., and Giudice, L. C. (2005) Dose-dependent insulin regulation of insulin-like growth factor binding protein-1 in human endometrial stromal cells is mediated by distinct signaling pathways. J. Clin. Endocrinol. Metab. 90, 1599-1606
21. Nayak, N. R., Kuo, C. J., Desai, T. A., Wiegand, S. J., Lasley, B. L., Giudice, L. C., and Brenner, R. M. (2005) Expression, localization and hormonal control of angiopoietin-1 in the rhesus macaque endometrium: potential role in spiral artery growth. Mol. Hum. Reprod. 11, 791-799
22. Kamba, T., Tam, B. Y., Hashizume, H., Haskell, A., Sennino, B., Mancuso, M. R., Norberg, S. M., O'Brien, S. M., Davis, R. B., Gowen, L. C., Anderson, K. D., Thurston, G., Joho, S., Springer, M. L., Kuo, C. J., and McDonald, D. M. (2006) VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am. J. Physiol. 290, H560-H576
23. Heryanto, B., Lipson, K. E., and Rogers, P. A. (2003) Effect of angiogenesis inhibitors on oestrogen-mediated endometrial endothelial cell proliferation in the ovariectomized mouse. Reproduction 125, 337-346
24. Hastings, J. M., Licence, D. R., Burton, G. J., Charnock-Jones, D. S., and Smith, S. K. (2003) Soluble vascular endothelial growth factor receptor 1 inhibits edema and epithelial proliferation induced by 17beta-estradiol in the mouse uterus. Endocrinology 144, 326-334
25. Benjamin, L. E., Golijanin, D., Itin, A., Pode, D., and Keshet, E. (1999) Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J. Clin. Invest. 103, 159-165
26. Singer, A. J., and Clark, R. A. (1999) Cutaneous wound healing. N. Engl. J. Med. 341, 738-746
27. Rak, J., Filmus, J., and Kerbel, R. S. (1996) Reciprocal paracrine interactions between tumour cells and endothelial cells: the "angiogenesis progression" hypothesis. Eur. J. Cancer 32A, 2480-2450
28. Semenza, G. L. (2000) HIF-1: using two hands to flip the angiogenic switch. Cancer Metastasis. Rev. 19, 59-65
29. Critchley, H. O., Osei, J., Henderson, T. A., Boswell, L., Sales, K. J., Jabbour, H. N., and Hirani, N. (2006) Hypoxia-inducible factor-1alpha expression in human endometrium and its regulation by prostaglandin E-series prostanoid receptor 2 (EP2). Endocrinology 147, 744-753
30. Sharkey, A. M., Day, K., McPherson, A., Malik, S., Licence, D., Smith, S. K., and Charnock-Jones, D. S. (2000) Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia. J. Clin. Endocrinol. Metab. 85, 402-409
31. Popovici, R. M., Irwin, J. C., Giaccia, A. J., and Giudice, L. C. (1999) Hypoxia and cAMP stimulate vascular endothelial growth factor (VEGF) in human endometrial stromal cells: potential relevance to menstruation and endometrial regeneration. J. Clin. Endocrinol. Metab. 84, 2245-2248
32. Zhang, J., and Salamonsen, L. A. (2002) Expression of hypoxia-inducible factors in human endometrium and suppression of matrix metalloproteinases under hypoxic conditions do not support a major role for hypoxia in regulating tissue breakdown at menstruation. Hum. Reprod. 17, 265-274
33. Daikoku, T., Matsumoto, H., Gupta, R. A., Das, S. K., Gassmann, M., DuBois, R. N., and Dey, S. K. (2003) Expression of hypoxia-inducible factors in the peri-implantation mouse uterus is regulated in a cell-specific and ovarian steroid hormone-dependent manner. Evidence for differential function of HIFs during early pregnancy. J. Biol. Chem. 278, 7683-7691
34. Folkman, J. (1971) Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285, 1182-1186
35. Franck-Lissbrant, I., Häggström, S., Damber, J. E., and Bergh, A. (1998) Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats. Endocrinology 139, 451-456